Abstract:
A cone light is a light emitting structure that is placed on a traffic cone to improve the visibility of the traffic cone. The light cone includes a plurality of lights that are mounted to an outer surface of the cone light and a micro-controller that controls the illumination of the lights. The cone right also has a memory storing a plurality of flash patterns and the micro-controller illuminates the lights in the flash pattern selected by the user. Multiple cone lights can be used together with a master cone light transmitting a flash pattern signal to one or more slave cone light so that each of the cone lights is illuminated in a matching or coordinated pattern.
Abstract:
A method of treatment or prophylaxis of amyloidosis disorders in a patient the method comprising topically applying to an area of skin of the patient a composition comprising: one or more zinc chelators; and one or more dermal penetration enhancers.
Abstract:
A topical cosmetic composition including: at least one water-soluble cosmetic agent; at least one oil-soluble cosmetic agent; and a dermal penetration enhancer, wherein topical application of the composition results in the delivery of the water-soluble and oil-soluble cosmetic agents into the stratum corneum as well as delivery of the oil-soluble cosmetic agent into the epidermis and dermis.
Abstract:
A cone light is a light emitting structure that is placed on a traffic cone to improve the visibility of the traffic cone. The light cone includes a plurality of lights that are mounted to an outer surface of the cone light and a micro-controller that controls the illumination of the lights. The cone light also has a memory storing a plurality of flash patterns and the micro-controller illuminates the lights in the flash pattern selected by the user. Multiple cone lights can be used together with a master cone light transmitting a flash pattern signal to one or more slave cone light so that each of the cone lights is illuminated in a matching or coordinated pattern.
Abstract:
A container includes a receptacle (6) for holding a substance, drug or liquid, and having an opening (7) to the receptacle 6 through which the substance can be dispensed and having a circular and domed spreading surface (15) adjacent the opening for spreading and the accurate delivery of a thin layer of liquid over an area of skin. The container also includes a closure (3) including a cap (4) having a seal or plug (16) for sealing the receptacle (6), and a collar (5) with a cam follower surface (8) rotatable relative to the cap about an axis, whereby rotation of the collar (5) relative to the cap (4) moves the seal in an axial direction away from a seal position.
Abstract:
The present invention presents a method, system and computer-implementable medium for remapping child references when parent reference updates are processed. The method includes the steps of creating a table that is used to store List Of Value (LOV) reference updates that need to be processed for remapping; creating triggers to populate the table dynamically as the LOV reference updates occur; extracting object mapping definitions from a definition repository; storing extracted object mapping definitions into a control table in memory; capturing LOV reference updates dynamically as they occur and populating the updates in the table via the triggers; matching the extracted object mapping definitions with the LOV reference updates; and remapping child references of parent LOV data using matched object mapping definitions
Abstract:
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of a non-steroidal anti-inflammatory drug; at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester; and at least one volatile liquid. The invention also provides a method for administering at least one systemic or locally acting non-steroidal anti-inflammatory drug to an animal which comprises applying an effective amount of the non-steroidal anti-inflammatory drug in the form of the drug delivery system of the present invention.
Abstract:
The invention relates to a method for treatment or prophylaxis of a disease or condition in an animal comprising administering to a mucosal membrane of said animal in need of such treatment a therapeutically effective amount of a drug delivery system comprising at least one physiologically active agent or prodrug thereof and at least one penetration enhancer selected from safe ester sunscreens.
Abstract:
The present invention provides a pharmaceutical composition for transdermal delivery comprising; one or more physiologically active agents; and a volatile pharmaceutically acceptable solvent; and wherein the physiological active agent forms a metastable deposit upon evaporation of the volatile solvent.